LeidenForce23h ago

Tiny droplets, big potential.

Yale scientists studied 5,000 breakups to understand how droplets split under different conditions.

A step forward for microfluidics applications.

🔗 https://phys.org/news/2026-03-precise-droplet.html

#Microfluidics #dropletphysics #softmatter #MicroReactors #drugdelivery

Building a better, more precise droplet

A humble droplet can be an immensely useful tool for a number of fields, from medicine to manufacturing. Controlling the size of the droplet, though, is an important—and very tricky—task. With unprecedented precision, a team of researchers determined how droplets break up into smaller ones, at what size, and under what conditions. The results of this study are published in Soft Matter.

Phys.org
NewsletterTFApr 13

Medikamente Zielsicher – Eine Elektrisch Gesteuerte Freisetzung

Vienna researchers developed a new way to control medicine release using electricity and click chemistry. This could make treatments more effective and reduce side effects.

#PrecisionMedicine, #DrugDelivery, #TUViennna, #MedicalResearch, #ClickChemistry

https://newsletter.tf/vienna-scientists-control-medicine-release-electricity/

Vienna Scientists Use Electricity to Control Medicine Release for Better Treatment

Vienna researchers developed a new way to control medicine release using electricity and click chemistry. This could make treatments more effective and reduce side effects.

NewsletterTF
NewsletterTFApr 13

This new technology allows doctors to control exactly when and where medicine is released, unlike older methods that sent medicine all over the body.

#PrecisionMedicine, #DrugDelivery, #TUViennna, #MedicalResearch, #ClickChemistry
https://newsletter.tf/vienna-scientists-control-medicine-release-electricity/

Vienna Scientists Use Electricity to Control Medicine Release for Better Treatment

Vienna researchers developed a new way to control medicine release using electricity and click chemistry. This could make treatments more effective and reduce side effects.

NewsletterTF
BiostockFeb 25

Iconovo and Lonza Enter LOI for Strategic Partnership

Iconovo and Lonza have signed a Letter of Intent to establish a long-term collaboration focused on inhalable biologics. This agreement aims to secure their respective positions in the biological medicines sector. Jan Vertommen, VP at Lonza, confirmed the company's interest in inhalable therapies and the intent to expand cooperation with Iconovo.

#biotech #drugdelivery #lifescience #biostock

Industry ExaminerJan 13
Novartis just placed a $1.7B Alzheimer’s bet on a “boring” but decisive problem: BBB delivery. If only ~0.1% of IV antibodies reach the brain, “brain shuttles” could be the next moat. Full feature: https://biotech.industryexaminer.com/novartis-alzheimers-brain-shuttle-blood-brain-barrier/
#Biotech #Alzheimers #DrugDelivery #Neuroscience #TechNews
Novartis’s $1.7bn Alzheimer’s bet: the real battleground is the blood–brain barrier - Biotech Industry Examiner

On January 12, 2026, Novartis wrote a large cheque for a problem that sounds almost too basic for modern biotech: delivery. The Swiss drugmaker signed a

Biotech Industry Examiner
VTC News BotJan 3

Nhà khoa học trẻ TP.HCM phát triển vật liệu nano dẫn truyền thuốc trúng đích, hứa hẹn mở ra hướng mới trong điều trị ung thư. #nanotechnology #cancerresearch #TPHCM #khoahọc #y học #đột phá

#materials #science #research #oncology #innovation #Vietnam #HCMC #nanomaterials #drugdelivery #targetedtherapy

https://vtcnews.vn/nha-khoa-hoc-tre-tp-hcm-tao-vat-lieu-nano-huong-toi-dieu-tri-ung-thu-ar995149.html

Nhà khoa học trẻ TP.HCM tạo vật liệu nano hướng tới điều trị ung thư

Từ phòng thí nghiệm tại ĐHQG TP.HCM, nhà khoa học trẻ Mai Ngọc Xuân Đạt phát triển vật liệu nano dẫn truyền thuốc trúng đích, mở ra hướng mới trong điều trị ung thư.

Báo điện tử VTC News
Omni LettersJan 1

Microneedles that could revolutionize cancer immunotherapy.

Made from natural polysaccharides, the new microneedles not only deliver drugs but also activate the immune system, paving the way for more effective and less invasive anticancer therapies.

Read more: https://omniletters.com/microneedles-that-could-revolutionize-cancer-immunotherapy/

#CancerImmunotherapy #Microneedles #Immunotherapy #CancerResearch #Oncology #DrugDelivery #TransdermalDelivery #Biomaterials #Polysaccharides #Nanomedicine #science #cancer

Microneedles that could revolutionize cancer immunotherapy

Made from natural polysaccharides, the new microneedles not only deliver drugs but also activate the immune system, paving the way for more effective and less invasive anticancer therapies.

Omni Letters
Sinclair TaDec 12

MIT just took a swing at one of the most annoying parts of modern medicine: hours‑long IV antibody infusions.

Their team figured out how to pack antibodies into tiny solid particles—about 100 microns wide—that stay suspended in liquid at ~360 mg/mL. That’s concentrated enough to deliver a full dose in about 2 mL, i.e., a normal subcutaneous injection, not a 100 mL drip.

https://mit-ki.org/4aHnV27
#Biotech #Oncology #DrugDelivery #MIT

A new way to deliver antibodies could make treatment much easier for patients

MIT engineers discovered a way to make solid particles of highly concentrated antibodies, suspended in a solution. The advance represents a major step toward re-formulating antibodies so that they can be injected using a standard syringe.

MIT News | Massachusetts Institute of Technology
NewsrampNov 21
Dr. Muzykantov reveals breakthrough nanomedicine strategies in upcoming BOC Sciences webinar exploring vascular drug delivery targeting mechanisms and innovative therapeutic approaches #Nanomedicine #DrugDelivery
CSBJNov 16

🧬 Can molecular simulations transform the future of long-acting diabetes treatments?

🔗 In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.11.007

📚 CSBJ: https://www.csbj.org/

#MolecularDynamics #DiabetesResearch #Biotherapeutics #GLP1 #Albumin #DrugDelivery #Biomaterials #ComputationalBiology #ProteinEngineering